MK-4318

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-4318, covering 2024-11-18 to 2024-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of MK-4318 and Diltiazem in Healthy People (MK-4318-003) [Phase 1]